Corporate News     27-Jan-23
Gland Pharma's Visakhapatnam facility concludes USFDA inspection
Gland Pharma announced that the United States Food and Drug Administration (US FDA) conducted an inspection at the Company's API Facility at JNPC, Visakhapatnam from 23 January 2023 to 27 January 2023 and has been completed with Zero observations.
Previous News
  Benchmarks trade with significant gains; VIX tumbles 9.39%
 ( Market Commentary - Mid-Session 07-Aug-24   12:36 )
  Gland Pharma Ltd soars 0.73%, up for fifth straight session
 ( Hot Pursuit - 16-May-24   13:00 )
  Gland Pharma fixes record date for final dividend
 ( Market Beat - Reports 22-May-24   19:56 )
  Gland Pharma allots 1800 equity shares under ESOS
 ( Corporate News - 24-Nov-22   18:34 )
  Gland Pharma Ltd spurts 2.01%, gains for third straight session
 ( Hot Pursuit - 27-Dec-23   13:05 )
  Gland Pharma consolidated net profit declines 15.05% in the December 2022 quarter
 ( Results - Announcements 23-Jan-23   17:31 )
  Gland Pharma schedules board meeting
 ( Corporate News - 20-Jul-24   12:06 )
  Gland Pharma to conduct AGM
 ( Corporate News - 18-May-21   12:01 )
  Gland Pharma Ltd leads losers in 'A' group
 ( Hot Pursuit - 21-Jul-22   15:00 )
  Gland Pharma consolidated net profit rises 144.56% in the March 2024 quarter
 ( Results - Announcements 23-May-24   07:36 )
  Gland Pharma consolidated net profit rises 33.69% in the March 2021 quarter
 ( Results - Announcements 17-May-21   17:20 )
Other Stories
  360 ONE WAM grants 21.47 lakh stock options
  05-Oct-24   11:32
  CARE reaffirms ratings on bank facilities of PNC Infratech's subsidiaries
  05-Oct-24   10:45
  CG Power & Industrial Solutions to acquire radio frequency components biz of Renesas
  05-Oct-24   10:30
  MMP Industries to convene board meeting
  05-Oct-24   10:23
  Mahindra & Mahindra Financial Serv. to discuss results
  05-Oct-24   10:23
  Ambey Laboratories to hold board meeting
  05-Oct-24   10:23
  Aurobindo Pharma's step down subsidiary to divest its entire stake in JV 'Novagen'
  05-Oct-24   10:21
  Aurobindo Pharma's step down subsidiary to divest its entire stake in a South African JV
  05-Oct-24   10:19
  Just Dial announces board meeting date
  05-Oct-24   10:11
  L&T Finance schedules board meeting
  05-Oct-24   10:11
Back Top